AI is Powering the Next Era of Precision Performance

Artificial intelligence (AI) is opening the door to a fundamentally different way of developing and commercializing therapies. Its ability to predict what matters, optimize what works and automate execution can reshape how decisions are made and work gets done across the therapeutic lifecycle. We envision AI embedded into everyday workflows, moving insights more readily into action and enabling each decision to inform what happens next.

At Syneos Health, we are putting that vision into practice across clinical development and commercialization. We apply AI within the workflows our teams know deeply to reduce friction between decisions and execution, surface the right insights at the right time and apply what we learn to continually improve performance.

Our approach remains human-led and grounded in responsible AI. As these capabilities evolve, we will continue putting technology to work alongside the deep scientific, operational and commercial expertise of our teams to help customers make better decisions, execute with greater precision and move therapies to patients with greater speed and confidence.